Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT04978948

Study of STIM1 Membrane Expression

Conditions: Autoimmune Diseases

Sex: All

Ages: 18 Years – 99 Years

Healthy volunteers: No

Enrollment: 670

Sponsor: University Hospital, Brest

Location: CHRU de Brest - Service de rhumatologie Brest Brest

Summary

The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM. This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of one of the autoimmune diseases Exclusion Criteria: * Treatment with rituximab in the previous 12 months

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04978948). StuddyBuddy aggregates publicly available trial information.